Public Notices
STATE OF WISCONSIN
CONTROLLED SUBSTANCES BOARD
---------------------------------------------------------------------
IN THE MATTER OF RULE-MAKING : AFFIRMATIVE ACTION
PROCEEDINGS BEFORE THE : ORDER OF THE
CONTROLLED SUBSTANCES BOARD : CONTROLLED SUBSTANCES BOARD
---------------------------------------------------------------------
FINDINGS
1. On July 2, 2014, the United States Food and Drug Administration, Drug Enforcement Administration published its final rule in the Federal Register placing tramadol (2- [(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol) into schedule IV of the federal Controlled Substances Act. The scheduling action is effective August 18, 2014.
2. The Controlled Substances Board did not receive an objection to similarly treating tramadol as a schedule IV under ch.
961, Stats. within 30 days of the date of publication in the federal register of the final order designating tramadol as a controlled substance.
3. The Controlled Substances Board will promulgate a final rule, without making the determinations or findings required by ss.
961.11(1),
(1m),
(1r) and
(2) or s.
961.19 and omitting the notice of proposed rule making, designating tramadol as a schedule IV controlled substance.
ORDER
Pursuant to s.
961.11(4), Stats., the Controlled Substances Board by affirmative action similarly treats tramadol under chapter 961, Stats. by creating the following:
CSB 2.36 Addition of tramadol to schedule IV. Section
961.20(4)(e), Stats., is created to read:
961.20(4)(e) Tramadol, including any of its isomers and salts of isomers.
This order shall take effect on September 1, 2014 to allow for publication in the Administrative Register. The order expires upon promulgation of a final rule.
Dated August 14, 2014 /s/
Doug Englebert, Chair
Controlled Substances Board
